Search

Displaying results 21 to 30 of 683.

Research Group

Microbial Drugs

The majority of the medically important antibiotic drugs are derived from secondary metabolites, which are produced by bacteria and filamentous fungi. Despite intensive world-wide efforts using alternative approaches, no other concept could so far surpass the historically successful strategy to exploit biologically active natural products as candidates for anti-infective drugs. The recently observed, increasing resistance of the human pathogens against antibiotics has prompted us to intensify our search for novel lead structures from microorganisms and fungi, which can be used as anti-infective drugs.

Research Group

Laboratory of Transmission Immunology

Transmission of viruses is only possible during a specific time frame after infection: we can call this the “window of transmission”. A major gap in mitigating (e.g., airborne) transmission and closing this window quickly is the lack of understanding of critical immune determinants of efficient transmission. To be able to close the window of transmission through the design of better mitigation strategies, we develop a mechanistic understanding of the spatial and longitudinal interplay between virus tropism, innate and adaptive immune responses, changes in host physiology, and exhalation or shedding of infectious virus in droplets or fluids.

Persons

Jun Prof Dr Alexey Gurevich

Head of Research Group
Human-Microbe Systems Bioinformatics
HIPS
Persons

Prof Dr Rolf Müller

Persons

Prof Dr Kathrin de la Rosa

Research Group Leader
Personalised Immunotherapy
CiiM
Persons

Lisa Kaniewski

Team assistant
HZI Campus
Persons

Prof Dr Anna K. H. Hirsch

Head of Research Group
Drug Design and Optimization
HIPS
Persons

Prof Dr Olga Kalinina

Head of Research Group
Drug Bioinformatics
HIPS
Persons

Dr Kenan Bozhüyük

Research Group Leader
Synthetic biology of microbial natural products
HIPS
Persons

Dr Florian Hubrich

Natural products from underexplored pathways and extreme environments
HIPS